U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07725497) titled 'A Study of Luspatercept in People With Anemia' on July 21.
Brief Summary: The researchers are doing this study to test whether luspatercept works to improve hemoglobin levels in people with anemia caused by chronic kidney disease (CKD). The researchers will also test whether luspatercept is a safe treatment that causes few or mild side effects in participants.
Study Start Date: July 20
Study Type: INTERVENTIONAL
Condition:
Anemia
Chronic Kidney Disease
Intervention:
DRUG: Luspatercept
Luspatercept subcutaneous injection once every 3 weeks
Recruitment Status: RECRUITING
Sponsor: Memorial Sloan Kettering Cancer Center
Publis...